163
Views
40
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Quantitative Analysis of Breast Cancer Tissue Microarrays Shows High Cox-2 Expression Is Associated with Poor Outcome

, B.S., , M.D., Ph.D., , M.D., , M.D., Ph.D. & , M.D.
Pages 19-26 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Renato Franco, Michele Caraglia, Gaetano Facchini, Alberto Abbruzzese & Gerardo Botti. (2011) The role of tissue microarray in the era of target-based agents. Expert Review of Anticancer Therapy 11:6, pages 859-869.
Read now
Steve Goodison & Virginia Urquidi. (2008) Breast tumor metastasis: analysis via proteomic profiling. Expert Review of Proteomics 5:3, pages 457-467.
Read now

Articles from other publishers (38)

Hwe Hoon Chung, Seung Hee Seo, Hyemin Kim, Yuil Kim, Dong Wuk Kim, Kwang Hyuck Lee, Kyu Taek Lee, Jin Seok Heo, In Woong Han, Seon Mee Park, Kee-Taek Jang, Jong Kyun Lee & Joo Kyung Park. (2022) Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays. Gut and Liver 17:1, pages 159-169.
Crossref
Souvik Chakraborty, Chang Jiang, David Gau, Michael Oddo, Zhijie Ding, Laura Vollmer, Marion Joy, William Schiemann, Donna Beer Stolz, Andreas Vogt, Sujoy Ghosh & Partha Roy. (2018) Profilin-1 deficiency leads to SMAD3 upregulation and impaired 3D outgrowth of breast cancer cells. British Journal of Cancer 119:9, pages 1106-1117.
Crossref
Céline Gérard & Kristy A. Brown. (2018) Obesity and breast cancer – Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue. Molecular and Cellular Endocrinology 466, pages 15-30.
Crossref
Rosalie Lemay, Martin Lepage, Luc Tremblay, Hélène Therriault, Gabriel Charest & Benoit Paquette. (2017) Tumor Cell Invasion Induced by Radiation in Balb/C Mouse is Prevented by the Cox-2 Inhibitor NS-398. Radiation Research 188:6, pages 685-694.
Crossref
Feng Xu, Mengxin Li, Chao Zhang, Jianxiu Cui, Jun Liu, Jie Li & Hongchuan Jiang. (2016) Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis. Oncotarget 8:4, pages 6003-6012.
Crossref
Sandrine Tury, Véronique Becette, Franck Assayag, Sophie Vacher, Camille Benoist, Maud Kamal, Elisabetta Marangoni, Ivan Bièche, Florence Lerebours & Céline Callens. (2016) Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer . Oncotarget 7:51, pages 85124-85141.
Crossref
Laura W. Bowers & Linda A. deGraffenried. (2015) Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient Population. Current Pharmacology Reports 1:5, pages 336-345.
Crossref
Albert Gough, Timothy Lezon, James R. Faeder, Chakra Chennubhotla, Robert F. Murphy, Rebecca Critchley-Thorne & D. Lansing Taylor. 2015. The Molecular Basis of Cancer. The Molecular Basis of Cancer 369 392.e7 .
Allen D. Nicholson, Xiaojia Guo, Catherine A.W. Sullivan & Charles H. Cha. (2014) Automated Quantitative Analysis of Tissue Microarray of 443 Patients with Colorectal Adenocarcinoma: Low Expression of Bcl-2 Predicts Poor Survival. Journal of the American College of Surgeons 219:5, pages 977-987.
Crossref
Kailash Mosalpuria, Carolyn Hall, Savitri Krishnamurthy, Ashutosh Lodhi, D. Hallman, Mary Baraniuk, Anirban Bhattacharyya & Anthony Lucci. (2014) Cyclooxygenase‑2 expression in non‑metastatic triple‑negative breast cancer patients. Molecular and Clinical Oncology.
Crossref
Bar Chikman, Sergey Vasyanovich, Ron Lavy, Liliana Habler, Gleb Tolstov, Andronik Kapiev, Ariel Halevy & Judith Sandbank. (2014) COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patients. Medical Oncology 31:6.
Crossref
Valsamo K. Anagnostou & David L. Rimm. 2015. Molecular Oncology. Molecular Oncology 76 84 .
G Bouchard, G Bouvette, H Therriault, R Bujold, C Saucier & B Paquette. (2013) Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases. British Journal of Cancer 109:7, pages 1829-1838.
Crossref
Benoit Paquette, Hélène Therriault & J. Richard Wagner. (2013) Role of Interleukin-1β in Radiation-Enhancement of MDA-MB-231 Breast Cancer Cell Invasion. Radiation Research 180:3, pages 292-298.
Crossref
Norazalina Saad, Norhaizan Mohd Esa & Hairuszah Ithnin. (2013) Suppression of β-catenin and Cyclooxygenase-2 Expression and Cell Proliferation in Azoxymethane-Induced Colonic Cancer in Rats by Rice Bran Phytic Acid (PA). Asian Pacific Journal of Cancer Prevention 14:5, pages 3093-3099.
Crossref
Byeong-Woo Park, Seho Park, Hyung Seok Park, Ja Seung Koo, Woo Ick Yang, Jun Sang Lee, Hyewon Hwang, Seung Il Kim & Kyong Sik Lee. (2012) Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes. Breast Cancer Research and Treatment 133:2, pages 741-751.
Crossref
Jocelyn Reader, Dawn Holt & Amy Fulton. (2011) Prostaglandin E2 EP receptors as therapeutic targets in breast cancer. Cancer and Metastasis Reviews 30:3-4, pages 449-463.
Crossref
B Paquette, H Therriault, G Desmarais, R Wagner, R Royer & R Bujold. (2011) Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor. British Journal of Cancer 105:4, pages 534-541.
Crossref
Sondes Karray-Chouayekh, Fatma Trifa, Abdelmajid Khabir, Noureddine Boujelbene, Tahia Sellami-Boudawara, Jamel Daoud, Mounir Frikha, Ali Gargouri & Raja Mokdad-Gargouri. (2010) Methylation status and overexpression of COX-2 in Tunisian patients with ductal invasive breast carcinoma. Tumor Biology 32:3, pages 461-468.
Crossref
Johanna G. H. van Nes, Esther M. de Kruijf, Dana Faratian, Cornelis J. H. van de Velde, Hein Putter, Claire Falconer, Vincent T. H. B. M. Smit, Charlene Kay, Marc J. van de Vijver, Peter J. K. Kuppen & John M. S. Bartlett. (2010) COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients. Breast Cancer Research and Treatment 125:3, pages 671-685.
Crossref
M. Doré. (2010) Cyclooxygenase-2 Expression in Animal Cancers. Veterinary Pathology 48:1, pages 254-265.
Crossref
Sharon A Glynn, Robyn L Prueitt, Lisa A Ridnour, Brenda J Boersma, Tiffany M Dorsey, David A Wink, Julie E Goodman, Harris G Yfantis, Dong H Lee & Stefan Ambs. (2010) COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer. BMC Cancer 10:1.
Crossref
M. HAYSAM KHOUJA, MARK BAEKELANDT, AGKHA SARAB, JAHN M. NESLAND & RUTH HOLM. (2010) Limitations of tissue microarrays compared with whole tissue sections in survival analysis. Oncology Letters 1:5, pages 827-831.
Crossref
Javier de la Torre, M. Dolors Sabadell, Federico Rojo, Jose Luis Lirola, Sabina Salicru, Jaume Reventos, Santiago Ramón y Cajal & Jordi Xercavins. (2010) Cyclo-oxygenase type 2 is dysregulated in breast ductal carcinoma in situ and correlates with poor outcome. European Journal of Obstetrics & Gynecology and Reproductive Biology 151:1, pages 72-76.
Crossref
Sung-Im DoGou Young KimSung-Jig LimYoun Wha Kim. (2010) Expression of Cyclooxygenase-2 and Embryonic Lethal Abnormal Vision-Like Protein HuR in Gallbladder Carcinoma. The Korean Journal of Pathology 44:1, pages 42.
Crossref
Marisa Dolled-Filhart, Mark Gustavson, Robert L. Camp, David L. Rimm, John L. Tonkinson & Jason Christiansen. 2010. Tissue Microarrays. Tissue Microarrays 151 162 .
Anthony Lucci, Savitri Krishnamurthy, Balraj Singh, Isabelle Bedrosian, Funda Meric-Bernstam, James Reuben, Kristine Broglio, Kailash Mosalpuria, Ashutosh Lodhi, Laura Vincent & Massimo Cristofanilli. (2008) Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow. Breast Cancer Research and Treatment 117:1, pages 61-68.
Crossref
Mark Gustavson, Marisa Dolled‐Filhart, Jason Christiansen, Robert Pinard & David Rimm. 2009. Molecular Pathology in Drug Discovery and Development. Molecular Pathology in Drug Discovery and Development 295 333 .
Moon-Il Park, Song-Yi Choi, Sun-Young Na & Dae Young Kang. (2009) p53 gene mutation and COX-2 expression in hepatocellular carcinoma. Basic and Applied Pathology 2:2, pages 47-52.
Crossref
C.A.W. Sullivan, S. Ghosh, I.T. Ocal, R.L. Camp, David L. Rimm & G.G. Chung. (2009) Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer. Human Pathology 40:2, pages 156-165.
Crossref
Yuxin Li & Powel H. Brown. 2009. Hormone Receptors in Breast Cancer. Hormone Receptors in Breast Cancer 1 35 .
Arndt-Christian Müller, René Handrick, Simon Johannes Elsaesser, Justine Rudner, Guido Henke, Ute Ganswindt, Claus Belka & Verena Jendrossek. (2008) Importance of Bak for celecoxib-induced apoptosis. Biochemical Pharmacology 76:9, pages 1082-1096.
Crossref
Catherine Conway, Lynne Dobson, Anthony O’Grady, Elaine Kay, Sean Costello & Daniel O’Shea. (2008) Virtual microscopy as an enabler of automated/quantitative assessment of protein expression in TMAs. Histochemistry and Cell Biology 130:3, pages 447-463.
Crossref
Bruce G. Haffty, Qifeng Yang, Meena S. Moran, Antoinette R. Tan & Michael Reiss. (2008) Estrogen-Dependent Prognostic Significance of Cyclooxygenase-2 Expression in Early-Stage Invasive Breast Cancers Treated With Breast-Conserving Surgery and Radiation. International Journal of Radiation Oncology*Biology*Physics 71:4, pages 1006-1013.
Crossref
Catherine A.W. Sullivan & Gina G. Chung. (2008) Biomarker Validation: In Situ Analysis of Protein Expression Using Semiquantitative Immunohistochemistry-Based Techniques. Clinical Colorectal Cancer 7:3, pages 172-177.
Crossref
Sung-Im Do, Eduard Santini Araujo, Ricardo K Kalil, Patrizia Bacchini, Franco Bertoni, K Krishnan Unni & Yong-Koo Park. (2018) Expression of Embryonic Lethal Abnormal Vision (ELAV)-Like Protein HuR and Cyclooxygenase-2 (COX-2) in Ewing Sarcoma. Tumori Journal 94:3, pages 347-350.
Crossref
Eun Seog KimDoo Ho ChoiSo Young JinDong Wha LeeHee Sook ParkMin Hyuk LeeJong Ho WonYong Ho KimKyu Taek LeeSung Yong Kim. (2008) The Role of Immunohistochemical Biomarkers as Prognostic Factors by the Use of a Tissue Microarray in Breast Cancer Patients Under 45-years-old. The Journal of the Korean Society for Therapeutic Radiology and Oncology 26:1, pages 45.
Crossref
. (2007) Cyclo-oxygenase 2 expression correlates with poor prognosis in breast cancer. Nature Clinical Practice Oncology 4:6, pages 332-332.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.